Skip to content
10-Q

Quarterly Report

NU-MED PLUS, INC. NUMD

0001575872-26-000326

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 14, 2026 83.55M sh
Shares Diluted Q1 2026 · Mar 31, 2026 83.55M sh
Shares Diluted Q1 2026 · Mar 31, 2025 83.55M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$6.38K
Operating Cash Flow Q1 2026 · Mar 31, 2025 $0
Long Term Debt Q1 2026 · Mar 31, 2026 $0
Long Term Debt Q1 2026 · Dec 31, 2025 $0
Stockholders Equity Q1 2026 · Mar 31, 2026 −$287.16K
Stockholders Equity Q1 2026 · Dec 31, 2025 −$271.28K
Stockholders Equity Q1 2026 · Mar 31, 2025 −$235.03K
Stockholders Equity Q1 2026 · Dec 31, 2024 −$215.1K
Current Liabilities Q1 2026 · Mar 31, 2026 $294.34K
Current Liabilities Q1 2026 · Dec 31, 2025 $279.19K
Total Liabilities Q1 2026 · Mar 31, 2026 $294.34K
Total Liabilities Q1 2026 · Dec 31, 2025 $279.19K
Current Assets Q1 2026 · Mar 31, 2026 $7.18K
Current Assets Q1 2026 · Dec 31, 2025 $7.91K
Total Assets Q1 2026 · Mar 31, 2026 $7.18K
Total Assets Q1 2026 · Dec 31, 2025 $7.91K
Eps Basic Q1 2026 · Mar 31, 2026 $0.00
Eps Basic Q1 2026 · Mar 31, 2025 $0.00
Sga Expense Q1 2026 · Mar 31, 2026 $4.83K
Sga Expense Q1 2026 · Mar 31, 2025 $5.71K
Net Income Q1 2026 · Mar 31, 2026 −$15.88K
Net Income Q1 2026 · Mar 31, 2025 −$19.93K
Operating Income Q1 2026 · Mar 31, 2026 −$13.15K
Operating Income Q1 2026 · Mar 31, 2025 −$18.7K
Revenue Q1 2026 · Mar 31, 2026 $0
Revenue Q1 2026 · Mar 31, 2025 $0